Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).

NCT02228798 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT02228798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02228798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Lead sponsor
McMaster University
Phase
Observational
Overall status
Completed
Start date
August 1, 2014
Completion date
August 31, 2018
Enrollment
3,135 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation